Dysregulation of the Coagulation System in Patients with Prostate and Bladder Cancer
Abstract
Hemostatic disorders are frequent complication at patients with malignancy, resulting to decrease in efficiency of treatment, increase of its cost. Effective prevention and therapy are impossible without an adequate estimation of changes in coagulation system. Goal in writing this short review is to summarize the literature data about the hemostatic disorders in patient with prostate and bladder cancer.
About the Author
G. A. Konstantinova
Rostov State Medical University
Russian Federation
Russian Federation
Department of Anesthesiology and Reanimatology
29, Nachichevansky st., Rostov-on-Don, 344022References
1. Shen V.S., Pollak E.W. Fatal pulmonary embolism in cancer patient: is heparin justifed? //Southern Medical Journal. – 1980. – V.73(7). – P.285-291.
2. White R.H., Zhou H., Romano P.S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures //Thrombosis and haemostasis. – 2003. – V.90. – P.446-455.
3. Rice K.R., Brassell S.A., McLeod D.G. Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment //Reviews in urology. – 2010. – V.12. – P.111-24.
4. Cohen A.T., Tapson V.F., Bergmann J.F., Goldhaber S.Z., Kakkar A.K., Deslandes B. et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study //Lancet. - 2008. - V.371. – P.387-394.
5. Moser K.M. Thromboembolic disease in the patient undergoing urologic surgery //The Urologic clinics of North America. – 1983. – V.10. – V.101–108.
6. Middleton A.W. Pelvic lymphadenectomy with modified radical retropubic prostatectomy as a single operation: technique used and results in 50 consecutive cases //The Journal of urology. – 1981. – V.125. – P.353-356.
7. Catalona W.J., Carvalhal G.F., Mager D.E., Smith D.S. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies //The Journal of urology. – 1999. – V.162. – P.433–438.
8. Gheiler E.L., Lovisolo J.A., Tiguert R., et al. Results of a clinical care pathway for radical prostatectomy patients in an open hospital-multiphysician system //European urology. – 1999. – V.35. – P.210-216.
9. Koya M.P., Manoharan M., Kim S.S., Soloway M.S. Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted? //BJU international. – 2005. – V.96(7). – P.1019-21.
10. Rosario D.J., Becker M., Anderson J.B. The changing pattern of mortality and morbidity from radical cystectomy //BJU international. – 2000. – V.85. – P.427-430.
11. Haas S., Wolf H., Kakkar A.K., et al. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin //Thrombosis and haemostasis. – 2005. – V.94. – P.814-819.
12. Donat R., Mancey-Jones B. Incidence of thromboembolism after transurethral resection of the prostate (TURP)-a study on TED stocking prophylaxis and literature review // Scandinavian journal of urology and nephrology. – 2002. – V.36. – P.119–123.
13. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., Colwell C.W. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) // Chest. – 2008. – V.133. - P.381S-453S.
14. Petroski R.A., Griewe G.L., Schenkman N.S. Delayed life-threatening hemorrhage after transrectal prostate needle biopsy //Prostate cancer and prostatic diseases. – 2003. – V.6(2). – P.190-2.
15. Deme D., Ragán M., Kalmár K., Kovács L., Varga E., Varga T., Rakonczai E. Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case //Hungarian oncology. – 2010. – V. 54(4). – P.351-7.
16. Kavanagh L.E., Jack G.S., Lawrentschuk N. Prevention and management of TURP-related hemorrhage //Nature reviews. Urology. – 2011. – V. 8(9). – P.504-14.
17. Scarpa R.M., Carrieri G., Gussoni G., et al. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study //European urology. – 2007. – V.51. – P.130-135.
18. Ziegler S., Ortu A., Reale C., Proietti R. et al. Fibrinolysis or hypercoagulation during radical prostatectomy? An evaluation of thrombelastographic parameters and standard laboratory tests //European journal of anaesthesiology. – 2008. – V.25(7). – 538-543.
19. Langer F., Chun F.K., Amirkhosravi A. et al. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers // Thrombosis and haemostasis. – 2007. – V.97(3). – P.464-470.
20. Tagawa S.T., Dorff T.B., Rochanda L. et al. Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy //BJU international. – 2008. – V.102(9). – P.1086-1091.
21. Shariat S.F., Roehrborn C.G., McConnell J.D., Park S., Alam N., Wheeler T.M., Slawin K.M. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis //Journal of clinical oncology: official journal of the American Society of Clinical Oncology. – 2007. – V.25(4). – P.349-55.
22. Tomiyama Y., Kimura H., Kitahata H. et al. Blood coagulation-fibrinolysis system during transurethral resection evaluated by thrombelastography // Masui. The Japanese journal of anesthesiology. – 1996. – V.45(5). – P.565-570.
23. Tauzin-Fin P., Sesay M., Ryman A., Ballanger P., Combe C. Postoperative thrombotic microangiopathy following radical cystectomy for bladder cancer //Anaesthesia and intensive care. – 2006. – V.34(5). – P.672-5.
24. Djukic Filimonovic J., Tulic C., Dzamic Z., Krivic B., Milkovic B., Markovic B., Hadzi Djokic J. Elevated plasma D-dimer as a predictor of postoperative complications after radical cystectomy //Acta chirurgica Iugoslavica. – 2007. – V.54(4). – P.93-6.
25. Shariat S.F., Monoski M.A., Andrews B., et al: Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder // Urology. – 2003. – V.61. - 1053-1058.
26. Шиффман Ф. Дж. Патофизиология крови. Пер. с англ. - М.-СПб.: «Издательство БИНОМ»-«Невский Диалект», 2000. – 448 с.
27. Okajima K., Kohno I., Tsuruta J. et al. Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer //Thrombosis research. – 1992. – V.66(6). – P.717-727.
28. Kohli M., Fink L.M., Spencer H.J., Zent C.S. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer //Blood Coagulation and Fibrinolysis. – 2002. – V.13. – P.1-5.
29. de la Fouchardière C., Flechon A., Droz J.P. Coagulopathy in prostate cancer //The Netherlands journal of medicine. – 2003. – V.61(11). – P.347-54.
30. Albiges L., Cottu P.H., Cojean-Zelek I. Haematological complications of prostatic cancer: 2 cases, one revealing the neoplasia //La Revue de médecine interne /fondée ... par la Société nationale francaise de médecine interne. – 2007. – V.28(3). – P.176-178.
31. Lim H.Y., Agarwal A.M., Agarwal N., Ward J.H. Recurrent epistaxis as a presenting sign of androgen-sensitive metastatic prostate cancer //Singapore medical journal. – 2009. – V.50(5). – P.178-180.
32. Duran I., Tannock I.F. Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer //Journal of general internal medicine. – 2006. – V.21(11). – P.6-8.
33. Joly L.M., Sermet A., Turak B. Massive haemorrhage after dorsal decompressive laminectomy //Annales françaises d’anesthèsie et de rèanimation. – 2005. – V.24(10). – P.1278-1281.
34. Navarro M., Ruiz I., Martín G., Cruz J.J. Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy //Prostate cancer and prostatic diseases. – 2006. – V.9(2). – P.190-191.
35. Goyal S., Goel R. Orbital haemorrhage with loss of vision in a patient with disseminated intravascular coagulation and prostatic carcinoma //Orbit. – 2004. – V.23(3). – P.193-197.
36. Iwan-Zietek I., Zietek Z., Kotschy M. et al. Disseminated intravascular coagulation syndrome with secondary fibrinolysis activation in prostatic carcinoma //Polski tygodnik lekarski/organ Polskiego Towarzystwa Lekarskiego. – 1996. – V.51(6-9). – P.100-101.
37. Benizri E, Raucoules-Aimé M, Amiel J. Coagulation disorders after endoscopic resection of the prostate // The Journal of urology. – 1994. – V.100(6). – P.299-303..
Review
For citations:
Konstantinova G.A. Dysregulation of the Coagulation System in Patients with Prostate and Bladder Cancer. Medical Herald of the South of Russia. 2011;(4):8-11. (In Russ.)
Views:
290
Email this article 